We have developed a novel in vitro model of the glial scar that mimics the gradient of proteoglycan found in vivo after spinal cord injury. In this model, regenerated axons from adult sensory neurons that extended deeply into the gradient developed bulbous, vacuolated endings that looked remarkably similar to dystrophic endings formed in vivo. We demonstrate that despite their highly abnormal appearance and stalled forward progress, dystrophic endings are extremely dynamic both in vitro and in vivo after spinal cord injury. Time-lapse movies demonstrated that dystrophic endings continually send out membrane veils and endocytose large membrane vesicles at the leading edge, which were then retrogradely transported to the rear of the "growth cone." This direction of movement is contrary to membrane dynamics that occur during normal neurite outgrowth. As further evidence of this motility, dystrophic endings endocytosed large amounts of dextran both in vitro and in vivo. We now have an in vitro model of the glial scar that may serve as a potent tool for developing and screening potential treatments to help promote regeneration past the lesion in vivo.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729861PMC
http://dx.doi.org/10.1523/JNEUROSCI.0994-04.2004DOI Listing

Publication Analysis

Top Keywords

dystrophic endings
16
vitro model
12
model glial
12
glial scar
12
spinal cord
12
cord injury
12
vivo spinal
8
vitro vivo
8
dystrophic
5
vitro
5

Similar Publications

Oligodendrocyte precursor cells stop sensory axons regenerating into the spinal cord.

Cell Rep

September 2023

Department of Neural Sciences, Shriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA. Electronic address:

Primary somatosensory axons stop regenerating as they re-enter the spinal cord, resulting in incurable sensory loss. What arrests them has remained unclear. We previously showed that axons stop by forming synaptic contacts with unknown non-neuronal cells.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates various treatment methods for degenerative-dystrophic damage to the spine and aims to identify the most effective approaches based on the underlying causes of pain.
  • It highlights the lack of consensus on effective treatments among healthcare providers, noting that no single therapy consistently alleviates symptoms of back pain and related syndromes.
  • The research emphasizes the importance of combining rest, pain relief, and movement, with a focus on nonsteroidal anti-inflammatory drugs (NSAIDs) initially, and suggests more advanced local drug administration methods if initial treatments are ineffective.
View Article and Find Full Text PDF

Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.

Neurosci Lett

May 2021

Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.

The major characteristics of Alzheimer's disease (AD) are amyloid plaques, consisting of aggregated beta amyloid (Aβ) peptides, together with tau pathology (tangles, neuropil treads and dystrophic neurites surrounding the plaques), in the brain. Down's syndrome (DS) individuals are at increased risk to develop AD-type pathology; most DS individuals have developed substantial pathology already at the age of 40. DS individuals have an extra copy of chromosome 21, harbouring the amyloid precursor protein gene (APP).

View Article and Find Full Text PDF

Recessive dystrophic epidermolysis bullosa (RDEB) is an incurable inherited mucocutaneous fragility disorder characterized by recurrent blisters, erosions, and wounds. Continuous blistering triggers overlapping cycles of never-ending healing and scarring commonly evolving to chronic systemic inflammation and fibrosis. The systemic treatment with allogeneic mesenchymal cells (MSC) from bone marrow has previously shown benefits in RDEB.

View Article and Find Full Text PDF

A view from the ending: Axonal dieback and regeneration following SCI.

Neurosci Lett

June 2017

Burke Medical Research Institute, White Plains, NY, United States; Weill Cornell Medicine, Feil Family Brain and Mind Research Institute, New York, NY, United States. Electronic address:

Following spinal cord injury (SCI), most axons fail to regenerate and instead form large, swollen endings generically called 'retraction bulbs.' These endings form and persist after SCI even under experimental therapeutic conditions where significant CNS regeneration occurs. Although retraction bulbs can arise from either activation of degenerative processes or deficits in regenerative processes, they are typically grouped as a single type of axonal ending.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!